JANICE TAVARES: Open Payments
NPI 1609428721 · BRIDGEPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,891 in 189 payments from 37 companies in 2025. Trend: 2023 $2,725 · 2024 $3,501 · 2025 $4,891
Food & beverage: $4,891
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $580 |
| Novo Nordisk Inc | 20 | $443 |
| ABBVIE INC. | 14 | $391 |
| Alnylam Pharmaceuticals Inc. | 8 | $380 |
| Amgen Inc. | 11 | $309 |
| PFIZER INC. | 15 | $280 |
| E.R. Squibb & Sons, L.L.C. | 21 | $257 |
| Lilly USA, LLC | 7 | $245 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $240 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $183 |
Products named: AMVUTTRA, VRAYLAR, Wegovy, Repatha, JARDIANCE, ELIQUIS, AIRSUPRA, MOUNJARO.
Industry payments across CT — which companies pay providers there.
